From January 2, 2024 to March 22, 2024, the company has repurchased 25,000,000 shares, representing 1.99% for CNY 140.76 million. With this, the company has completed the repurchase of 25,000,000 shares, representing 1.99% for CNY 140.76 million under the buyback announced on January 3, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.6 CNY | +4.87% | +7.90% | -4.76% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.76% | 941M | |
+31.35% | 662B | |
+21.96% | 546B | |
-5.29% | 359B | |
+16.96% | 323B | |
+4.74% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+3.92% | 167B |
- Stock Market
- Equities
- 002550 Stock
- News Changzhou Qianhong Biopharma CO.,LTD
- Tranche Update on Changzhou Qianhong Biopharma CO.,LTD's Equity Buyback Plan announced on January 3, 2024.